Siemens healthineers wants to grow with ki

Siemens healthineers wants to grow with ki

Siemens healthineers aims to achieve sustainable growth with modern imaging, remote operating room transmission and the increasing use of artificial intelligence in medicine.

In the medium term, the medical technology group aims to increase sales by five percent per year and earnings per share by ten percent per year, as announced by group ceo bernd montag in erlangen.

In the past fiscal year 2018/2019, the company, with 52.000 employees, sales jumped from 13.43 billion euros to 14.52 billion euros. Profit after taxes rose from 1.28 to 1.59 billion euros. But healthineers slightly missed profitability targets. The reason for this was start-up difficulties with the new atellica laboratory diagnostics system. The group expects profits to continue to rise in the coming years thanks to good business with so-called imaging processes. However, growth was allowed to slow down compared to the fiscal year just ended. The share price started trading with a jump of more than five percent.

Healthineers, which is based in erlangen, germany, was able to make gains above all in imaging and in the still comparatively small advanced therapies segment. Hospitals of the future to become more digital and technologically advanced. It’s about "doing more and more with less and less," montag said. Technical solutions, for example to make interventions minimally invasive, to use robots or to treat patients remotely, are to help in this process. Thanks to new technologies, the operator no longer has to stand at the table the whole time, but can use a kind of control desk to guide catheters, for example to place stents that keep blood vessels open.

The company has high hopes for the atellica system, which is expected to bring laboratory diagnostics, which has been weak for a long time, back to the forefront – but is currently still making losses. The planned target of achieving an adjusted operating margin in the mid-teens has therefore been postponed by two years to 2024. "We won’t make it in the timeframe we had hoped for," said montag.

The manufacturer of nuclear spin and computer tomography scanners emerged from the medical technology division of siemens, but has been operating independently since going public almost two years ago. Siemens remains majority shareholder with 85 percent of the shares.

Leave a Reply

Your email address will not be published.